Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
9 Dec 2025
What Cabin Filters and Face Masks Reveal About Plane and Hospital Air
Metagenomic profiling of airborne microbial communities is opening new windows on pathogen risks in crowded transport.
9 Dec 2025
Glycolytic Pathways Drive Systemic Inflammation in Dermatomyositis
Fibroblasts fuel skin and systemic inflammation via a CXCL10–glycolysis axis in dermatomyositis, offering new metabolic treatment opportunities.
12
Mins
9 Dec 2025
American College of Rheumatology Convergence 2025
THE AMERICAN College of Rheumatology (ACR) Convergence returned to Chicago, Illinois, USA, this year, and with it brought thousands of…
9 Dec 2025
Ovarian Cancer Treatment is Increasingly Individualised
Up to 70% of patients with advanced Stage III–IV high-grade OC will relapse, and >80% of patients with late-stage OC will become platinum…
3
Mins
9 Dec 2025
Effectiveness of SC vs IV Natalizumab
Subcutaneous administration of natalizumab provides similar real-world effectiveness to intravenous administration, providing a convenient…
1
Mins
9 Dec 2025
Financial Toxicity in Rheumatic Disease, Cancer, and Their Intersection
Financial toxicity (FT) is the financial burden of accessing healthcare. It is well known in cancer and increasingly seen in rheumatic…
4
Mins
9 Dec 2025
ANCA Vasculitis Presenting With Bilateral Toe Cyanosis
Blue toe syndrome (BTS) presents as a sudden development of localized blue or purple discoloration of one or more toes, typically…
9 Dec 2025
AMJ’s Latest Rheumatology Journal
Our latest AMJ Rheumatology Journal is now live with ACR 2025 coverage. Discover the shift toward earlier, mechanism-based treatments that…
1
Mins
9 Dec 2025
Oral Glucocorticoids Do Not Affect PFS in Checkpoint Inhibitor Associated Arthritis
Immune checkpoint inhibitors (ICI) are efficacious treatments for various cancers. As approvals for ICI treatment increase for additional…
4
Mins
9 Dec 2025
GLP-1 Receptor Agonists in Osteoarthritis
THIS YEAR, at the American College of Rheumatology (ACR) Convergence 2025, a dedicated session explored whether glucagon-like peptide-1…
←
1
2
3
…
11
12
13
14
15
16
17
…
1,414
1,415
1,416
→
We’ve noticed you’re accessing
from
North/South America.
View
View